Item 5. Market for Registrant’s Common Equity
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market
Information
On
February 17, 2021, we completed a public offering of 6,210,000 shares of our common stock, inclusive of the underwriters’ full
overallotment, at $10.00 per share for total gross offering proceeds of $62,100,000. In connection with the offering, we received approval
to list our common stock on the Nasdaq Capital Market under the symbol “UGRO”. Prior to the offering, shares of our common
stock were quoted on the OTC Markets Group, Inc. OTCQX Marketplace under the symbol “UGRO”. Although our shares were quoted
on the OTCQX Marketplace from October 7, 2019 through February 11, 2021, because trading on the OTCQX Marketplace was infrequent and
limited in volume, the prices at which such transactions occurred did not necessarily reflect the price that would have been paid for
our common stock in a more liquid market.
The
trading price of our common stock has been, and may continue to be, subject to wide price fluctuations in response to various factors,
many of which are beyond our control, including those described in Part I, Item 1A, “Risk Factors.”
The following table sets forth the high and low closing
bid price information for our common stock on the Nasdaq Capital Market for the time periods indicated. Prior to February
12, 2021, our common stock was traded on the OTCQX Marketplace. Trading activity for our common stock on the OTCQX Marketplace
can be found at www.otcmarkets.com .
Quarter Ended
Low
High
December 31, 2021
$ 8.78
$ 14.77
September 30, 2021
$ 8.51
$ 17.30
June 30, 2021
$ 6.75
$ 10.50
February 12 thru March 31, 2021
$ 6.90
$ 13.80
Holders
As
of March 26, 2021, we had 6,846 holders of record for our Common Stock.
28
Dividend
Policy
Since
our inception, we have not paid any dividends on our common stock, and we currently expect that, for the foreseeable future, all earnings,
if any, will be retained for use in the development and operation of our business. In the future, our Board may decide, at its discretion,
whether dividends may be declared and paid to holders of our common stock.
Reports
We
are subject to certain reporting requirements and furnish annual financial reports to our stockholders, certified by our independent
accountants, and furnish unaudited quarterly financial reports in our quarterly reports filed electronically with the SEC. All reports
and information filed by us can be found at the SEC website, www.sec.gov.
ReCENT
SALES OF UNREGISTERED SECURTIES
During
the years ended December 31, 2020 and 2021, we issued the following securities that were not registered under the Securities
Act:
●
On
February 21, 2020, we entered into a letter agreement (the “Credit Agreement”) by and among us, as borrower, urban-gro
Canada Technologies Inc. and Impact Engineering, Inc., as guarantors, the lenders party thereto, and Bridging Finance Inc., as administrative
agent for the lenders (the “Agent”). As additional consideration for the entering into the Credit Agreement, we issued
83,333 shares of our common stock and warrants to purchase 20,746 shares of common stock with an exercise price of $14.46 per share
to the Agent. We relied upon the exemption from registration provided by Section 4(a)(2) of the Securities Act to issue the securities.
●
On
December 15, 2020, we signed a $1,854,500 convertible note (the “Notes”) bridge financing (the “Bridge Financing”).
The Bridge Financing is a combination of $1,354,500 received on November 20, 2020, and an additional $500,000 received on December
15, 2020. The Bridge Financing was raised by a combination of our Board of Directors, our current investors and two new institutional
funds. In connection with the Bridge Financing, an outstanding $1,000,000 promissory note and $4,500 interest accrued thereon was
converted into a Note. The Notes were issued in reliance upon the exemption from registration under Section 4(a)(2) of the Securities
Act. The Notes carried interest at the rate of 12% and were scheduled to mature on December 31, 2021. Pursuant to the mandatory conversion
provisions therein, the Notes plus accrued interest of $53,725 were converted into 254,430 shares of common stock upon completion
of the public offering described in more detail below.
Completion
of Registered Public Offering
On
February 11, 2021, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity, a
division of Fordham Financial Management, Inc. (the “Underwriter”), relating to the Company’s underwritten public offering
of its common stock. Pursuant to the Underwriting Agreement, the Company agreed to sell 5,400,000 shares of Common Stock to the Underwriter
at a public offering price of $10.00 per share, and granted the Underwriter a 45-day over-allotment option to purchase up to 810,000
additional shares of Common Stock, equivalent to 15% of the shares of Common Stock sold in the Offering (the “Option”), pursuant
to the Company’s registration statement on Form S-1 (File Nos. 333-250120 and 333-253011) (the “Registration Statement”),
under the Securities Act of 1933. The offering closed on February 17, 2021, and the Company sold 6,210,000 shares of Common Stock to
the Underwriter for total gross proceeds of $62.1 million, which includes 810,000 shares sold upon the full exercise of the Option. After
deducting the underwriting commissions, discounts, and offering expenses, the Company received net proceeds of approximately $57.4
million. On February 17, 2021, pursuant to the Underwriting Agreement, the Company issued the Warrants to purchase up to an aggregate
of 310,500 shares of Common Stock. The Warrants may be exercised beginning on August 11, 2021 until February 11, 2026. The initial exercise
price of each Warrant is $12.50 per share, which represents 125% of the Offering Price. On February 19, 2021 we used $5.8 million of
the net proceeds to repay outstanding under and terminated the Credit Agreement. We intend to use the remaining net proceeds to support
our organic growth, to expand in the European CEA market and for other general corporate purposes, including to fund potential future
investments and acquisitions of companies that we believe are complementary to our business and consistent with our growth strategy.
Although we may, from time to time, evaluate potential strategic investments and acquisitions, we do not have any definitive agreements
in place to make any such acquisitions at this current time. The expected use of net proceeds from the offering represents our intentions
based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve and
change. As a result, our management will have broad discretion over how these proceeds are used. The remaining net proceeds will be invested
in short-term investments until needed for the uses described above.
Item
6. [RESERVED]
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.